Market Forecast By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, Antitumor Antibiotic), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Leukemia, Ovarian Cancer), By Route of Drug Administration (Intravenous, Oral, Subcutaneous, Intra-Muscular, Intravesicular, Topical, Intraperitoneal, Intraventricular/Intrathecal), By End-Users (Specialty Centers, Hospitals & Clinics) And Competitive Landscape
Product Code: ETC044944 | Publication Date: Jun 2023 | Updated Date: Jan 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Report Name | India Chemotherapy Market |
Forecast Period | 2025-2031 |
CAGR | 11.4% |
Growing Sector | Healthcare Sector |
The India Chemotherapy Market Report thoroughly covers the market by drug class, indication, route of drug administration, and end-users. The India Chemotherapy Market Outlook report provides an unbiased and detailed analysis of the ongoing India Chemotherapy Market trends, opportunities/high growth areas, and market drivers. This would help the stakeholders devise and align their market strategies according to the current and future market dynamics.
India chemotherapy market has been growing and is projected to accomplish prominent growth in the future since the market presents a significant opportunity for cancer care in India. Key players in this industry are working towards developing new and innovative chemotherapy drugs while expanding their existing product lines.
According to 6Wresearch, the India Chemotherapy Market size is estimated to grow at a CAGR of 11.4% during 2025-2031. A significant driver of the Indian chemotherapy market is the rising incidence of cancer in India. With the increasing number of cases, the demand for chemotherapy is also on the rise. Improved access to medical care is also a significant driver, with more and more Indians seeking medical treatment in recent years. Additionally, advancements in chemotherapy technologies and the development of new chemotherapy drugs have also contributed to the India chemotherapy market growth.
One of the significant hurdles is the high cost of chemotherapy drugs, which makes the treatment inaccessible for many patients. Additionally, there is a shortage of oncologists and trained medical staff, limiting the reach of cancer care services. Poor infrastructure and lack of funding also pose challenges to the development of cancer treatment centers and the availability of chemotherapy. Lastly, the COVID-19 pandemic has disrupted cancer care services in India, with many patients experiencing delays or interruptions in their treatment.
Several key players dominate the Indian chemotherapy market, including Mylan, Biocon, Cipla, Hetero Healthcare, Natco Pharma, and Sun Pharmaceuticals. These companies are focused on developing new and innovative chemotherapy drugs while expanding their product line. They are also investing in research and development, partnerships, and collaborations to improve cancer care in India.
The Indian government has initiated several programs aimed at improving cancer care in the country. These programs include funding for cancer research, the establishment of new cancer treatment centers, and the training of oncologists and medical staff. Additionally, the government has launched several schemes to provide financial assistance to those in need of cancer treatment. The National Cancer Control Program has also been launched to improve the prevention and treatment of cancer in India.
India Chemotherapy market is poised to grow in the coming years, driven by an increase in the incidence of cancer, the government's supportive initiatives, and technological advancements in cancer treatment. The emergence of targeted therapy and the adoption of robotic technology have added new dimensions to cancer treatment in India. Nevertheless, the market still faces challenges such as the lack of adequate infrastructure and high costs. The future of the market is optimistic, and the resolve of cancer researchers and healthcare professionals to conquer cancer is getting stronger.
According to Sachin, Senior Research Analyst, 6Wreserach, alkylating agents in the market are the oldest and the most widely used in India. These drugs work by damaging the DNA of cancer cells, preventing them from dividing and growing.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Chemotherapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Chemotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Chemotherapy Market - Industry Life Cycle |
3.4 India Chemotherapy Market - Porter's Five Forces |
3.5 India Chemotherapy Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Chemotherapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2021 & 2031F |
3.8 India Chemotherapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 India Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Chemotherapy Market Trends |
6 India Chemotherapy Market, By Types |
6.1 India Chemotherapy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Chemotherapy Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 India Chemotherapy Market Revenues & Volume, By Alkylating Agents, 2021 - 2031F |
6.1.4 India Chemotherapy Market Revenues & Volume, By Mitotic Inhibitors, 2021 - 2031F |
6.1.5 India Chemotherapy Market Revenues & Volume, By Antimetabolites, 2021 - 2031F |
6.1.6 India Chemotherapy Market Revenues & Volume, By Topoisomerase Inhibitors, 2021 - 2031F |
6.1.7 India Chemotherapy Market Revenues & Volume, By Antitumor Antibiotic, 2021 - 2031F |
6.2 India Chemotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Chemotherapy Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 India Chemotherapy Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 India Chemotherapy Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 India Chemotherapy Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F |
6.2.6 India Chemotherapy Market Revenues & Volume, By Stomach Cancer, 2021 - 2031F |
6.2.7 India Chemotherapy Market Revenues & Volume, By Lymphoma, 2021 - 2031F |
6.2.8 India Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.2.9 India Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.3 India Chemotherapy Market, By Route of Drug Administration |
6.3.1 Overview and Analysis |
6.3.2 India Chemotherapy Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.3 India Chemotherapy Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.4 India Chemotherapy Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.5 India Chemotherapy Market Revenues & Volume, By Intra-Muscular, 2021 - 2031F |
6.3.6 India Chemotherapy Market Revenues & Volume, By Intravesicular, 2021 - 2031F |
6.3.7 India Chemotherapy Market Revenues & Volume, By Topical, 2021 - 2031F |
6.3.8 India Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2021 - 2031F |
6.3.9 India Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2021 - 2031F |
6.4 India Chemotherapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Chemotherapy Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4.3 India Chemotherapy Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
7 India Chemotherapy Market Import-Export Trade Statistics |
7.1 India Chemotherapy Market Export to Major Countries |
7.2 India Chemotherapy Market Imports from Major Countries |
8 India Chemotherapy Market Key Performance Indicators |
9 India Chemotherapy Market - Opportunity Assessment |
9.1 India Chemotherapy Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Chemotherapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2021 & 2031F |
9.4 India Chemotherapy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 India Chemotherapy Market - Competitive Landscape |
10.1 India Chemotherapy Market Revenue Share, By Companies, 2024 |
10.2 India Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |